TOR1AIP2
Torsin-1A-interacting protein 2
Also known as: IFRG15, LULL1, NET9, TOIP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFQ8
- Gene
- TOR1AIP2
- Ensembl
- ENSG00000169905
- Chromosome
- 1
- Canonical length
- 470 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
One of the two protein isoforms encoded by this gene is a type II integral membrane protein found in the endoplasmic reticulum (ER). The encoded protein is a cofactor for the ATPase TorsinA, regulating the amount of TorsinA present in the ER compared to that found in the nuclear envelope. Defects in this protein are a cause of early onset primary dystonia, a neuromuscular disease. The other isoform encoded by this gene is an interferon alpha responsive protein whose cellular role has yet to be determined. [provided by RefSeq, Mar 2017]
Canonical amino-acid sequenceUniProt
470 residues, UniProt reviewed canonical sequence.
>Q8NFQ8|TOR1AIP2
1 MADSGLREPQ EDSQKDLEND PSVNSQAQET TIIASNAEEA EILHSACGLS KDHQEVETEG
61 PESADTGDKS ESPDEANVGK HPKDKTEDEN KQSFLDGGKG HHLPSENLGK EPLDPDPSHS
121 PSDKVGRADA HLGSSSVALP KEASDGTGAS QEPPTTDSQE AQSPGHSSAG QEGEDTLRRR
181 LLAPEAGSHP QQTQKLEEIK ENAQDTMRQI NKKGFWSYGP VILVVLVVAV VASSVNSYYS
241 SPAQQVPKNP ALEAFLAQFS QLEDKFPGQS SFLWQRGRKF LQKHLNASNP TEPATIIFTA
301 AREGRETLKC LSHHVADAYT SSQKVSPIQI DGAGRTWQDS DTVKLLVDLE LSYGFENGQK
361 AAVVHHFESF PAGSTLIFYK YCDHENAAFK DVALVLTVLL EEETLEASVG PRETEEKVRD
421 LLWAKFTNSD TPTSFNHMDS DKLSGLWSRI SHLVLPVQPV SSIEEQGCLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TOR1AIP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 39 nTPM
- liver: 39 nTPM
- placenta: 21 nTPM
- small intestine: 19 nTPM
- epididymis: 18 nTPM
- adrenal gland: 18 nTPM
Single-cell type
- esophageal apical cells: 439 nCPM
- enterocytes: 356 nCPM
- extravillous trophoblasts: 314 nCPM
- hepatocytes: 307 nCPM
- syncytiotrophoblasts: 258 nCPM
- neutrophils: 235 nCPM
Immune cell
- basophil: 21 nTPM
- neutrophil: 13 nTPM
- plasmacytoid DC: 8.9 nTPM
- intermediate monocyte: 8.2 nTPM
- non-classical monocyte: 8.2 nTPM
- eosinophil: 7.6 nTPM
Brain region
- choroid plexus: 51 nTPM
- midbrain: 49 nTPM
- hypothalamus: 49 nTPM
- hippocampal formation: 46 nTPM
- pons: 45 nTPM
- thalamus: 45 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
OntologyGO
Biological processes
- endoplasmic reticulum organization
- membrane organization
- positive regulation of ATP-dependent activity
- protein localization to nuclear envelope
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TOR1AIP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TOR1AIP2 as an antibody target. Whether an autoantibody or antibody against TOR1AIP2 could matter depends on whether native TOR1AIP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TOR1AIP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TOR1AIP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...